Mineralys Therapeutics, Inc. Current Ratio in % from Q3 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Mineralys Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2023 to Q3 2025.
  • Mineralys Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 2.03K %, a 53.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Mineralys Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 2.03K +706 +53.4% Sep 30, 2025
Q2 2025 1.43K -220 -13.4% Jun 30, 2025
Q1 2025 1.31K -982 -42.9% Mar 31, 2025
Q4 2024 1.22K -1.38K -53.2% Dec 31, 2024
Q3 2024 1.32K -1.08K -45% Sep 30, 2024
Q2 2024 1.65K Jun 30, 2024
Q1 2024 2.29K Mar 31, 2024
Q4 2023 2.6K Dec 31, 2023
Q3 2023 2.4K Sep 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.